Related Experiment Video

Updated: May 7, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

The relation between location of paravalvular leakage and time to reoperation after mitral valve replacement

Mehmet Yanartaş1, Serdar Demir, Ayşe Baysal

  • 1Clinics of Cardiovascular Surgery Kartal Koşuyolu Yüksek İhtisas Education and Training Hospital; İstanbul-Turkey. elnur17@yahoo.com.

Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology
|September 26, 2013
PubMed
Abstract

Insights

The location of paravalvular leakage (PVL) after mitral valve replacement impacts reoperation time. Leaflet PVL leads to longer intervals before reoperation compared to commissural PVL.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Imaging

Background:

  • Paravalvular leakage (PVL) is a complication after mitral valve replacement.
  • The location of PVL may influence clinical outcomes and the need for reoperation.

Purpose of the Study:

  • To investigate the relationship between the location of paravalvular leakage (PVL) and the time to reoperation following mitral mechanical valve replacement.

Main Methods:

  • Retrospective observational study of 47 patients with clinical and echocardiographic follow-up for five years.
  • Patients were categorized into Leaflet (Group 1) and Commissural (Group 2) PVL based on echocardiography.
  • Demographics, preoperative variables, reoperation causes, and time from PVL diagnosis to reoperation were analyzed.

Main Results:

  • PVL was diagnosed at a median of 180 days post-mitral valve replacement; median follow-up was 5 years.
  • No significant differences in age, gender, ejection function, or leak characteristics between groups.
  • Time to reoperation was significantly longer for leaflet PVL (39.0 months) versus commissural PVL (19.5 months) (p=0.002).
  • 30-day mortality for reoperation was 4.3%, with higher mortality in the leaflet PVL group (9.8% vs. 0%, p=0.002).

Conclusions:

  • The time interval from diagnosis to reoperation is longer for leaflet PVL compared to commissural PVL.
  • Echocardiographic assessment of PVL location is crucial for patient follow-up after mitral valve replacement.

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.